Raymond James Downgrades Boston Scientific to Outperform, Lowers Price Target to $88

Benzinga Newsdesk www.benzinga.com Negative 92.5%

Neg 92.5% Neu 0% Pos 0%

Raymond James analyst Jayson Bedford downgrades Boston Scientific (NYSE:BSX) from Strong Buy to Outperform and lowers the price target from $97 to $88.